Release Date: 19/08/20 11:42 Summary: Becoming a substantial holder from CBA Price Sensitive: No Download Document 213.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%